Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001140361-25-007769
Filing Date
2025-03-10
Accepted
2025-03-10 07:58:09
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 ny20045079x1_s3.htm S-3 351307
2 EXHIBIT 5.1 ny20045079x1_ex5-1.htm EX-5.1 10919
3 EXHIBIT 23.1 ny20045079x1_ex23-1.htm EX-23.1 1641
4 EXHIBIT 23.2 ny20045079x1_ex23-2.htm EX-23.2 2283
5 FILING FEES TABLE ny20045079x1_ex107.htm EX-FILING FEES 12859
6 logo_gracetherapeutics.jpg GRAPHIC 48372
7 ny20045079x1_ex5-1image01.jpg GRAPHIC 727516
  Complete submission text file 0001140361-25-007769.txt   1448748
Mailing Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 609-322-1602
Grace Therapeutics, Inc. (Filer) CIK: 0001444192 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0331
Type: S-3 | Act: 33 | File No.: 333-285661 | Film No.: 25722185
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)